Ototoxicity of high‐dose cisplatin by bolus administration in patients with advanced cancers and normal hearing
Open Access
- 1 August 1988
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 98 (8) , 858-864
- https://doi.org/10.1288/00005537-198808000-00014
Abstract
Our institution undertook a phase I trial to define the toxicity of high-dose (150 to 225 mg) bolus administration (every 3 to 4 weeks) of cisplatin in patients with advanced cancers. All patients re...Keywords
This publication has 22 references indexed in Scilit:
- Ototoxicity of cisplatinInternational Journal of Andrology, 1987
- Detection of Ototoxicity by High-Frequency Auditory EvaluationSeminars in Hearing, 1985
- Ototoxicity of low- and moderate-dose cisplatinCancer, 1985
- Cisplatin Potentiation of Radiotherapy: Long-term Follow-upJAMA Otolaryngology–Head & Neck Surgery, 1985
- Inner ear histopathology in patients treated with Cis‐Platinum.The Laryngoscope, 1982
- Ototoxicity of the Anticancer Drug Cisplatin:An Experimental StudyActa Oto-Laryngologica, 1982
- Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patientsJournal of Surgical Oncology, 1981
- Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatmentCancer, 1979
- cis-Platinum OtotoxicityClinical Toxicology, 1978
- Effect of absence of cochlear outer hair cells on behavioural auditory thresholdNature, 1975